We are a global venture fund with A$2.2bn AUM and presence in UK, US, and AUS/NZ. Our team has deep technical expertise, as well as entrepreneurial background, and can provide support from pre-seed to commercialisation. We are looking for breakthrough new science and technology, addressing large global markets, led by exceptional founders, and with the passion to make a positive impact on the world. IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK’s largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
There doesn't seem to be anything here at this time
